Packaging means for multi-dose powder inhalers with optimized discharging properties
Details for Australian Patent Application No. 2007229530 (hide)
International Classifications
Event Publications
6 November 2008 PCT application entered the National Phase
PCT publication WO2007/110402 Priority application(s): WO2007/110402
13 November 2008 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Boehringer Ingelheim Pharma GmbH, Application No. 2007229530, under INID (71), correct the name to read Boehringer Ingelheim International GmbH Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002236526 The Government of the United States of America, represented by The Secretary, Departm
27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007229531-Dosage aerosols for the administration of pharmaceutical preparations
2007229522-Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser